Acetaminophen Completed Phase 2 Trials for Multiple Myeloma (MM) Treatment

CompletedTreatment2 IdentifierTitleDrugs
NCT01985126An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD